Anastrozole/levonorgestrel intravaginal ring - Bayer HealthCare

Drug Profile

Anastrozole/levonorgestrel intravaginal ring - Bayer HealthCare

Alternative Names: BAY 98-7196; Bay98-7196

Latest Information Update: 15 Nov 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Bayer HealthCare
  • Class Nitriles; Norpregnanes; Oral contraceptives; Small molecules; Triazoles
  • Mechanism of Action Aromatase inhibitors; Estrogen receptor antagonists; Progesterone receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase III Pregnancy
  • Phase II Endometriosis

Most Recent Events

  • 01 Oct 2016 Bayer completes a phase-II clinical trial in Endometriosis in Austria, Belgium, Canada, Czech Republic, Denmark, Finland, Germany, Japan Netherlands, Norway, Poland, Spain, Switzerland and USA (NCT02203331)
  • 01 Jul 2016 Bayer completes a phase I trial for Endometriosis in Germany (NCT02545452)
  • 01 Jul 2016 Bayer completes a phase III trial for Contraception in USA and Japan (NCT02403401)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top